183 related articles for article (PubMed ID: 30126956)
1. Magnitude of Voriconazole Resistance in Clinical and Environmental Isolates of Aspergillus flavus and Investigation into the Role of Multidrug Efflux Pumps.
Paul RA; Rudramurthy SM; Dhaliwal M; Singh P; Ghosh AK; Kaur H; Varma S; Agarwal R; Chakrabarti A
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126956
[TBL] [Abstract][Full Text] [Related]
2. Voriconazole resistance genes in Aspergillus flavus clinical isolates.
Zaini F; Lotfali E; Fattahi A; Siddig E; Farahyar S; Kouhsari E; Saffari M
J Mycol Med; 2020 Jun; 30(2):100953. PubMed ID: 32362445
[TBL] [Abstract][Full Text] [Related]
3. Investigation of Multiple Resistance Mechanisms in Voriconazole-Resistant Aspergillus flavus Clinical Isolates from a Chest Hospital Surveillance in Delhi, India.
Sharma C; Kumar R; Kumar N; Masih A; Gupta D; Chowdhary A
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311090
[TBL] [Abstract][Full Text] [Related]
4. Investigation of Azole Resistance Involving
Ghorbel D; Amouri I; Khemekhem N; Neji S; Trabelsi H; Elloumi M; Sellami H; Makni F; Ayadi A; Hadrich I
Pol J Microbiol; 2024 Jun; 73(2):131-142. PubMed ID: 38700908
[TBL] [Abstract][Full Text] [Related]
5. Clinical epidemiology of pulmonary aspergillosis in hospitalized patients and contribution of Cyp51A, Yap1, and Cdr1B mutations to voriconazole resistance in etiologic Aspergillus species.
Salehi Z; Sharifynia S; Jamzivar F; Shams-Ghahfarokhi M; Poorabdollah M; Abtahian Z; Nasiri N; Marjani M; Moniri A; Salehi M; Tabarsi P; Razzaghi-Abyaneh M
Eur J Clin Microbiol Infect Dis; 2023 Jul; 42(7):853-864. PubMed ID: 37142789
[TBL] [Abstract][Full Text] [Related]
6. Antifungal susceptibility profile and molecular identification of Cyp51C mutations in clinical and environmental isolates of Aspergillus flavus from Argentina.
Hermida-Alava K; Brito Devoto T; Sautua F; Gordó M; Scandiani M; Formento N; Luque A; Carmona M; Cuestas ML
Mycoses; 2021 Jan; 64(1):95-101. PubMed ID: 33001518
[TBL] [Abstract][Full Text] [Related]
7. Contributions of both ATP-Binding Cassette Transporter and Cyp51A Proteins Are Essential for Azole Resistance in Aspergillus fumigatus.
Paul S; Diekema D; Moye-Rowley WS
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264842
[TBL] [Abstract][Full Text] [Related]
8. Microsatellite Typing and Resistance Mechanism Analysis of Voriconazole-Resistant
Choi MJ; Won EJ; Joo MY; Park YJ; Kim SH; Shin MG; Shin JH
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30397064
[TBL] [Abstract][Full Text] [Related]
9. Point Mutations in the 14-α Sterol Demethylase Cyp51A or Cyp51C Could Contribute to Azole Resistance in
Lucio J; Gonzalez-Jimenez I; Rivero-Menendez O; Alastruey-Izquierdo A; Pelaez T; Alcazar-Fuoli L; Mellado E
Genes (Basel); 2020 Oct; 11(10):. PubMed ID: 33080784
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of ATP-binding cassette and/or major facilitator superfamily class efflux pumps contributes to voriconazole resistance in Aspergillus flavus.
Natesan SK; Lamichchane AK; Swaminathan S; Wu W
Diagn Microbiol Infect Dis; 2013 Aug; 76(4):458-63. PubMed ID: 23886435
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterisation of cyp51A and cyp51B genes coding for P450 14alpha-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus.
Krishnan-Natesan S; Chandrasekar PH; Alangaden GJ; Manavathu EK
Int J Antimicrob Agents; 2008 Dec; 32(6):519-24. PubMed ID: 18775650
[TBL] [Abstract][Full Text] [Related]
12. The T788G mutation in the cyp51C gene confers voriconazole resistance in Aspergillus flavus causing aspergillosis.
Liu W; Sun Y; Chen W; Liu W; Wan Z; Bu D; Li R
Antimicrob Agents Chemother; 2012 May; 56(5):2598-603. PubMed ID: 22314539
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics of Voriconazole against Wild-Type and Azole-Resistant Aspergillus flavus Isolates in a Nonneutropenic Murine Model of Disseminated Aspergillosis.
Rudramurthy SM; Seyedmousavi S; Dhaliwal M; Chakrabarti A; Meis JF; Mouton JW
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821453
[TBL] [Abstract][Full Text] [Related]
14. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
15. A Novel Y319H Substitution in CYP51C Associated with Azole Resistance in Aspergillus flavus.
Paul RA; Rudramurthy SM; Meis JF; Mouton JW; Chakrabarti A
Antimicrob Agents Chemother; 2015 Oct; 59(10):6615-9. PubMed ID: 26248359
[TBL] [Abstract][Full Text] [Related]
16. Molecular Identification, Antifungal Susceptibility Testing, and Mechanisms of Azole Resistance in
Rivero-Menendez O; Soto-Debran JC; Medina N; Lucio J; Mellado E; Alastruey-Izquierdo A
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285229
[TBL] [Abstract][Full Text] [Related]
17. Aneuploidy Formation in the Filamentous Fungus Aspergillus flavus in Response to Azole Stress.
Barda O; Sadhasivam S; Gong D; Doron-Faigenboim A; Zakin V; Drott MT; Sionov E
Microbiol Spectr; 2023 Aug; 11(4):e0433922. PubMed ID: 37358460
[TBL] [Abstract][Full Text] [Related]
18. The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus.
Fraczek MG; Bromley M; Buied A; Moore CB; Rajendran R; Rautemaa R; Ramage G; Denning DW; Bowyer P
J Antimicrob Chemother; 2013 Jul; 68(7):1486-96. PubMed ID: 23580559
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
[TBL] [Abstract][Full Text] [Related]
20. Contributions of
Ukai Y; Kuroiwa M; Kurihara N; Naruse H; Homma T; Maki H; Naito A
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126960
[No Abstract] [Full Text] [Related]
[Next] [New Search]
